Stocks and Investing Stocks and Investing
Fri, July 28, 2017
Thu, July 27, 2017
Wed, July 26, 2017

Jeffrey Silber Maintained (BIIB) at Hold with Decreased Target to $285 on, Jul 26th, 2017


Published on 2024-10-25 21:55:44 - WOPRAI, Jeffrey Silber
  Print publication without navigation


Jeffrey Silber of BMO Capital, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $328 to $285 on, Jul 26th, 2017.

Jeffrey has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017


This is the rating of the analyst that currently disagrees with Jeffrey


  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017
Contributing Sources